| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |